Human nitric oxide synthase—Its functions, polymorphisms, and inhibitors in the context of inflammation, diabetes and cardiovascular diseases

M Król, M Kepinska - International journal of molecular sciences, 2020 - mdpi.com
In various diseases, there is an increased production of the free radicals needed to carry out
certain physiological processes but their excessive amounts can cause oxidative stress and …

Intrinsic disorder and posttranslational modifications: the darker side of the biological dark matter

AL Darling, VN Uversky - Frontiers in genetics, 2018 - frontiersin.org
Intrinsically disordered proteins (IDPs) and intrinsically disordered protein regions (IDPRs)
are functional proteins and domains that devoid stable secondary and/or tertiary structure …

PDE5 inhibitors–pharmacology and clinical applications 20 years after sildenafil discovery

KE Andersson - British journal of pharmacology, 2018 - Wiley Online Library
The discovery of the nitric oxide/cGMP pathway was the basis for our understanding of many
normal physiological functions and the pathophysiology of several diseases. Since the …

The role of Nrf2 in cardiovascular function and disease

S Satta, AM Mahmoud, FL Wilkinson… - Oxidative medicine …, 2017 - Wiley Online Library
Free radicals, reactive oxygen/nitrogen species (ROS/RNS), hydrogen sulphide, and
hydrogen peroxide play an important role in both intracellular and intercellular signaling; …

Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease

DI Lee, G Zhu, T Sasaki, GS Cho, N Hamdani… - Nature, 2015 - nature.com
Cyclic guanosine monophosphate (cGMP) is a second messenger molecule that transduces
nitric-oxide-and natriuretic-peptide-coupled signalling, stimulating phosphorylation changes …

Effects of canagliflozin on human myocardial redox signalling: clinical implications

H Kondo, I Akoumianakis, I Badi, N Akawi… - European Heart …, 2021 - academic.oup.com
Aims Recent clinical trials indicate that sodium-glucose cotransporter 2 (SGLT2) inhibitors
improve cardiovascular outcomes in heart failure patients, but the underlying mechanisms …

Angiogenic endothelial cell signaling in cardiac hypertrophy and heart failure

R Gogiraju, ML Bochenek, K Schäfer - Frontiers in cardiovascular …, 2019 - frontiersin.org
Endothelial cells are, by number, one of the most abundant cell types in the heart and active
players in cardiac physiology and pathology. Coronary angiogenesis plays a vital role in …

Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease

X Liu, X Xu, R Shang, Y Chen - Nitric oxide, 2018 - Elsevier
Patients with chronic kidney disease have an increased cardiovascular morbidity and
mortality. It has been recognized that the traditional cardiovascular risk factors could only …

Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy …

MF Yuyun, LL Ng, GA Ng - Microvascular research, 2018 - Elsevier
Homeostasis around vascular endothelium is a function of the equilibrium between the
bioavailability of nitric oxide (NO) and oxidizing reactive oxygen species (ROS). Within the …

How exercise may amend metabolic disturbances in diabetic cardiomyopathy

AD Hafstad, N Boardman, E Aasum - Antioxidants & redox signaling, 2015 - liebertpub.com
Significance: Over-nutrition and sedentary lifestyle has led to a worldwide increase in
obesity, insulin resistance, and type 2 diabetes (T2D) associated with an increased risk of …